Trileptal is a brand name of oxcarbazepine, approved by the FDA in the following formulation(s):
TRILEPTAL (oxcarbazepine - suspension; oral)
Manufacturer: NOVARTIS
Approval date: May 25, 2001
Strength(s): 300MG/5ML [RLD][AB]
TRILEPTAL (oxcarbazepine - tablet; oral)
Manufacturer: NOVARTIS
Approval date: January 14, 2000
Strength(s): 150MG [AB], 300MG [AB], 600MG [RLD][AB]
Has a generic version of Trileptal been approved?
A generic version of Trileptal has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Trileptal and have been approved by the FDA:
oxcarbazepine suspension; oral
Manufacturer: RANBAXY
Approval date: June 26, 2009
Strength(s): 300MG/5ML [AB]
oxcarbazepine tablet; oral
Manufacturer: APOTEX INC
Approval date: April 9, 2008
Strength(s): 150MG [AB], 300MG [AB], 600MG [AB]
Manufacturer: BRECKENRIDGE PHARM
Approval date: January 11, 2008
Strength(s): 150MG [AB], 300MG [AB], 600MG [AB]
Manufacturer: CADISTA PHARMS
Approval date: January 25, 2010
Strength(s): 150MG [AB], 300MG [AB], 600MG [AB]
Manufacturer: GLENMARK GENERICS
Approval date: October 9, 2007
Strength(s): 150MG [AB], 300MG [AB], 600MG [AB]
Manufacturer: ROXANE
Approval date: October 9, 2007
Strength(s): 150MG [AB], 300MG [AB], 600MG [AB]
Manufacturer: SUN PHARM INDS
Approval date: October 9, 2007
Strength(s): 150MG [AB], 300MG [AB], 600MG [AB]
Manufacturer: TARO
Approval date: November 15, 2007
Strength(s): 150MG [AB], 300MG [AB], 600MG [AB]
Manufacturer: TEVA PHARMS
Approval date: December 11, 2007
Strength(s): 150MG [AB], 300MG [AB], 600MG [AB]
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Trileptal. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.
Oxacarbazepine film-coated tablets
Patent 7,037,525
Issued: May 2, 2006
Inventor(s): Schlütermann; Burkhard
Assignee(s): Novartis AG
The invention relates to formulations, e.g. film-coated tablets containing oxcarbazepine and to processes for the production of said formulations. The film-coated tablets have a tablet core comprising a therapeutically effective dose of oxacarbazepine being in a finely ground form having a mean particle size of from 4 to 12 μm (median value), and a hydrophilic permeable outer coating.
Patent expiration dates:
See also...
- Trileptal Consumer Information (Drugs.com)
- Trileptal Consumer Information (Wolters Kluwer)
- Trileptal Suspension Consumer Information (Wolters Kluwer)
- Trileptal Consumer Information (Cerner Multum)
- Trileptal Advanced Consumer Information (Micromedex)
- Trileptal AHFS DI Monographs (ASHP)
- Oxcarbazepine Consumer Information (Wolters Kluwer)
- Oxcarbazepine Suspension Consumer Information (Wolters Kluwer)
- Oxcarbazepine Consumer Information (Cerner Multum)
- Oxcarbazepine Advanced Consumer Information (Micromedex)
- Oxcarbazepine AHFS DI Monographs (ASHP)